BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6422898)

  • 1. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the acute administration of molsidomine in refractory congestive heart failure. A double-blind randomized non-invasive study].
    Coletta C; Galati A; Carunchio A; Salustri A; Bordi L; Fera MS
    G Ital Cardiol; 1986 Mar; 16(3):232-6. PubMed ID: 3755412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical and hemodynamic results of molsidomine treatment in patients with refractory heart failure.
    Acar J; Kulas A; Escudier B
    Am Heart J; 1985 Mar; 109(3 Pt 2):685-7. PubMed ID: 3883737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic effects of molsidomine in chronic congestive heart failure].
    Humar F; Maras P; Musitelli G; Camerini F
    G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
    Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
    Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
    Larbig DT; Milstrey HR; Nasse H; Kahle T
    Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].
    Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute hemodynamic effects of SIN-1 and isosorbide dinitrate in stable left ventricular failure: a comparative double-blind, cross-over study].
    Himbert D; Spreux-Varoquaux O; Jaeger P; Himbert C; Cohen-Solal A; Advenier C; Gourgon R
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):455-62. PubMed ID: 1298186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
    Le Pailleur C; Baubion N; Metzger JP; Heulin A; Vacheron A; Di Matteo J
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):700-6. PubMed ID: 6431936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of korvatone on the hemodynamic indices of rheumatism patients].
    Sokolov AM; Suloeva MN
    Vrach Delo; 1984 Jul; (7):83-6. PubMed ID: 6548064
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamic effects of sublingual molsidomine in patients with or without cardiac failure].
    Rigaud M; Luwaert R; Jouret G; Bardet J; Bourdarias JP
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):523-8. PubMed ID: 6421222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
    Witchitz S; Kolsky H; Moisson P; Valette H
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
    Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
    Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of the preparation korvatone].
    Charchoglian RA; Esin NN; Belozerov GE
    Sov Med; 1982; (5):15-8. PubMed ID: 7051350
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects].
    Figulla HR; Luig H; Nieschlag F; Kreuzer H
    Z Kardiol; 1987 Mar; 76(3):167-74. PubMed ID: 3109142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molsidomine in the treatment of patients with angina pectoris.
    Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
    N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris].
    Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W
    Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.